ArticleBMC pediatrics2026
Multifactorial analysis of allergen-specific IgE sensitization in children with allergic diseases in Suzhou, China.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAllergic diseases represent a major public health challenge among children. Allergen sensitization patterns may be influenced by factors such as age, gender, season, and disease phenotype. This study aimed to systematically evaluate the associations of these factors with allergen sensitization patterns in children.
methodsWe studied 2,434 symptomatic children who underwent allergen testing at a district-level hospital in Suzhou, China, using the ImmunoCAP Phadia 250 system. Seventeen common airborne allergens (AAs) and food allergens (FAs) were assessed. The primary definition of sensitization was sIgE ≥ 0.35 IU/mL, whereas robustness analyses were additionally performed at thresholds of ≥ 0.70 and ≥ 3.50 IU/mL. Multivariable logistic regression models were used to evaluate associations with age, gender, and season, with false-discovery rate correction using the Benjamini-Hochberg method.
resultsPositivity rates varied systematically according to the sIgE threshold. As thresholds increased from grade ≥ 1 to ≥ 2 and ≥ 3, absolute positivity rates decreased as expected, whereas the direction of age-, gender-, and season-related patterns remained consistent. AA sensitization was more common than FA sensitization, with Dermatophagoides pteronyssinus and Dermatophagoides farinae representing the predominant sensitizers, whereas milk and egg were the leading food allergens. With increasing age, AA sensitization increased whereas FA sensitization declined; these patterns persisted after multivariable adjustment and at higher positivity thresholds. Males showed higher odds of sensitization, particularly for mite allergens. Seasonal variation was most evident for mite allergens, with higher positivity during summer-autumn than winter, broadly paralleling local humidity patterns. Across disease phenotypes, AA sensitization was more common in asthma and rhinitis, whereas FA sensitization was relatively more common in atopic dermatitis and the food-allergy group; mixed diseases showed a higher overall sensitization burden.
conclusionsIn this single-center referred cohort, the findings describe allergen test positivity among clinically tested children rather than population-level prevalence. Age, gender, season, and disease phenotype were associated with distinct sensitization patterns, supporting greater attention to mite-focused assessment and environmental control from school age onward, particularly during humid seasons, as well as milk and egg evaluation during early childhood. The overall findings remained consistent at stricter sIgE positivity thresholds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.